Title

Growth factor and cytokine interactions in myogenesis. Part II. Expression of IGF binding proteins and protein kinases essential for myogenesis in mouse C2C12 myogenic cells exposed to TNF-α and IFN-γ

Journal title

Polish Journal of Veterinary Sciences

Yearbook

2011

Issue

No 3

Authors

Wieteska-Skrzeczyńska, W. ; Grzelkowska-Kowalczyk, K. ; Rejmak, E.

Divisions of PAS

Nauki Biologiczne i Rolnicze

Publisher

Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn

Date

2011

Identifier

DOI: 10.2478/v10181-011-0063-2 ; ISSN 1505-1773

Source

Polish Journal of Veterinary Sciences; 2011; No 3

References

G Adams (2010), Insulin-like growth factor I signaling in skeletal muscle and the potential for cytokine interactions, Med Sci Sports Exerc, 42, 50, doi.org/10.1249/MSS.0b013e3181b07d12 ; S Adi (2002), Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation, Endocrinology, 143, 511, doi.org/10.1210/en.143.2.511 ; C De Alvaro (2008), Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kB are required for C2C12-RasV12C40 myoblast differentiation, Endocrinology, 149, 793, doi.org/10.1210/en.2007-0657 ; A de Thonel (2010), Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis, Mol Biol Cell, 21, 1423, doi.org/10.1091/mbc.E09-10-0847 ; C Duan (2010), Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation, Gen Comp Endocrinol, 167, 344, doi.org/10.1016/j.ygcen.2010.04.009 ; L Fernandez-Celemin (2002), Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-α, Am J Physiol Endocrinol Metab, 283. ; S Firth (2002), Cellular actions of the insulin-like growth factor binding proteins, Endocr Rev, 23, 824, doi.org/10.1210/er.2001-0033 ; K Grzelkowska-Kowalczyk (2010), Treatment with TNF-α and IFN-γ alters the activation of SER/THR protein kinases and the metabolic response to IGF-I in mouse C2C12 myogenic cells, Cell Mol Biol Lett, 15, 13, doi.org/10.2478/s11658-009-0033-1 ; J Hirosumi (2002), A central role for JNK in obesity and insulin resistance, Nature, 420, 333, doi.org/10.1038/nature01137 ; M Igarashi (2007), Characterization of activation of MAP kinase superfamily in vasculature from diabetic rats, J Atheroscler Thromb, 14, 235, doi.org/10.5551/jat.E514 ; S Jacobi (2006), Adipocytes, myofibers, and cytokine biology: new horizons in the regulation of growth and body composition, J Animal Sci, 84. ; E Jennische (2000), Expression and localisation of IGF-binding protein mRNAs in regenerating rat skeletal muscle, APMIS, 108, 747, doi.org/10.1034/j.1600-0463.2000.d01-24.x ; C Jo (2009), MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation, Cell Signal, 21, 1910, doi.org/10.1016/j.cellsig.2009.08.008 ; C Lang (2002), Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins in the catabolic response to injury and infection, Curr Opin Clin Nutr Metab Care, 5, 271, doi.org/10.1097/00075197-200205000-00006 ; F Mourkioti (2005), IGF-I, inflammation and stem cells: interactions during muscle regeneration, Trends Immunol, 26, 535, doi.org/10.1016/j.it.2005.08.002 ; Y Ning (2006), Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5, Mol Endocrinol, 20, 2173, doi.org/10.1210/me.2005-0196 ; G Nystrom (2009), Local insulin-like growth factor I prevents sepsis-induced muscle atrophy, Metabolism, 58, 787, doi.org/10.1016/j.metabol.2009.01.015 ; N Oksbjerg (2004), Basic principles of muscle development and growth in meat-producing mammals as affected by the insulin-like growth factor (IGF) system, Domest Anim Endocrinol, 27, 219, doi.org/10.1016/j.domaniend.2004.06.007 ; J Paye (2006), Regulation of insulin-like growth factor-I (IGF-I) delivery by IGF binding proteins and receptors, Ann Biomed Eng, 34, 618, doi.org/10.1007/s10439-005-9064-6 ; I Plaisance (2008), TNF-alpha increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK, Am J Physiol Endocrinol Metab, 294. ; J Schertzer (2007), Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice, Am J Pathol, 171, 1180, doi.org/10.2353/ajpath.2007.070292 ; A Solomon (2006), Modifying muscle mass - the endocrine perspective, J Endocrinol, 191, 349, doi.org/10.1677/joe.1.06837 ; J-P Thissen (2007), How proinflammatory cytokines may impair growth and cause muscle wasting, Horm Res, 67, 64, doi.org/10.1159/000097555 ; N Tiffin (2004), Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation, Endocrinology, 145, 4991, doi.org/10.1210/en.2004-0101 ; G Tripathi (2009), IGF-independent effects of insulin-like growth factor binding protein-5 (igfbp5) in vivo, FASEB J, 23, 2616, doi.org/10.1096/fj.08-114124 ; T Vary (2004), Diminished ERK 1/2 and p38 MAPK phosphorylation in skeletal muscle during sepsis, Shock, 22, 548, doi.org/10.1097/01.shk.0000144131.13900.ff< ; P Yin (2004), Paradoxical actions of endogenous and exogenous insulin-like growth factor-binding protein-5 revealed by RNA interference analysis, J Biol Chem, 279, 32660, doi.org/10.1074/jbc.M401378200